Stocktoria
Metavesco, Inc. MVCO
OTC · stock · Finance Services · website · IPO 1998-01-29
Metavesco, Inc. financials (annual, from 10-K)
Bars are annual figures from 2016 to 2023; red bars are negative (a loss or cash outflow).
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $127,087 | $82,617 | — | — | — | — | $192 | $34,743 |
| Gross profit | — | — | — | — | — | — | $192 | $34,743 |
| SG&A expense | $313,539 | $164,669 | $70,970 | $57,760 | $66,344 | $101,309 | $273,688 | $209,087 |
| Operating income | — | — | -$116,662 | -$128,467 | -$158,529 | -$140,851 | — | — |
| Interest expense | $97,432 | $12,761 | $45,692 | $70,707 | $92,185 | $39,542 | — | — |
| Net income | -$572,845 | -$1.1M | -$116,662 | -$128,467 | $10.4M | -$140,851 | -$373,921 | -$1.7M |
| EPS (diluted) | $-0.01 | $-0.02 | — | — | — | — | — | — |
| Operating cash flow | -$198,863 | -$153,308 | -$57,581 | -$56,368 | -$65,631 | -$94,714 | -$269,483 | -$174,213 |
| Cash & equivalents | $17,086 | $35,151 | $44 | — | — | — | — | $458,485 |
| Inventory | $7,788 | — | — | — | — | — | — | — |
| Total assets | $336,326 | $483,640 | $44 | $12,625 | $8,993 | $4,624 | $0 | $722,923 |
| Total liabilities | $329,925 | $139,310 | $208,368 | $134,287 | $192,188 | $10.7M | $10.6M | — |
| Shareholders' equity | $6,401 | $344,330 | -$208,324 | -$121,662 | -$183,195 | -$10.7M | -$10.6M | -$10.2M |
Growth · year-over-year · Revenue CAGR 54.1%
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | +53.8% | — | — | — | — | — | -99.4% | — |
| Net income growth | — | — | — | -101.2% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000924095 · US · as of 2023-06-30. facts plus Stocktoria's own computed scores — not investment advice.